Initiator Pharma A/S

Initiator Pharma A/Sverified

INIT.ST

Price:

$3.14

Market Cap:

$146.46M

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.

Industry

Biotechnology

IPO Date

2017-03-16

Stock Exchange

STO

Ticker

INIT.ST

The Enterprise Value as of December 2025 (TTM) for Initiator Pharma A/S (INIT.ST) is 143.95M

According to Initiator Pharma A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 143.95M. This represents a change of -33.82% compared to the average of 217.50M of the last 4 quarters.

Initiator Pharma A/S (INIT.ST) Historical Enterprise Value (quarterly & annually)

How has INIT.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Initiator Pharma A/S over the last ten years is 28.34M. The current 143.95M Enterprise Value has changed 50.70% with respect to the historical average. Over the past ten years (40 quarters), INIT.ST's Enterprise Value was at its highest in in the June 2024 quarter at 357.10M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

28.34M

Median

-13123181.73

Minimum

-26140691.43

Maximum

314.80M

Initiator Pharma A/S (INIT.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Initiator Pharma A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 104.79%

Maximum Annual Enterprise Value = 314.80M

Minimum Annual Increase = -1304.25%

Minimum Annual Enterprise Value = -26140691.43

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-13123181.73-104.17%
2023314.80M-1304.25%
2022-26140691.4326.59%
2021-20649805.0154.02%
2020-13406824.4485.57%
2019-7224781.65-49.28%
2018-14243454.90104.79%
2017-6955245.57-116.57%

Initiator Pharma A/S (INIT.ST) Average Enterprise Value

How has INIT.ST Enterprise Value performed in the past?

The current Enterprise Value of Initiator Pharma A/S (INIT.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

91.85M

5-year avg

48.30M

10-year avg

28.34M

Initiator Pharma A/S (INIT.ST) Enterprise Value vs. Peers

How is INIT.ST’s Enterprise Value compared to its peers?

Initiator Pharma A/S’s Enterprise Value is less than Bio-Works Technologies AB (publ) (164.97M), less than Lipum AB (publ) (336.26M), greater than IRLAB Therapeutics AB (publ) (116.55M), less than Isofol Medical AB (publ) (148.95M), greater than Annexin Pharmaceuticals AB (publ) (125.48M), greater than Karolinska Development AB (publ) (46.80M), less than iZafe Group AB (publ) (178.73M), less than SenzaGen AB (171.11M), less than Alzinova AB (publ) (200.41M), less than Clinical Laserthermia Systems AB (publ) (179.76M),

Build a custom stock screener for Initiator Pharma A/S (INIT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Initiator Pharma A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Initiator Pharma A/S (INIT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Initiator Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Initiator Pharma A/S's Enterprise Value?

What is the highest Enterprise Value for Initiator Pharma A/S (INIT.ST)?

What is the 3-year average Enterprise Value for Initiator Pharma A/S (INIT.ST)?

What is the 5-year average Enterprise Value for Initiator Pharma A/S (INIT.ST)?

How does the current Enterprise Value for Initiator Pharma A/S (INIT.ST) compare to its historical average?